Carson Wealth (CWM LLC)’s Mineralys Therapeutics MLYS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$164K	Buy	6,051 +953	+19%	+$27.9K	﹤0.01%	2892
2025 Q4	$185K	Sell	5,098 -499	-9%	-$20K	﹤0.01%	2632
2025 Q3	$212K	Sell	5,597 -654	-10%	-$14.1K	﹤0.01%	2395
2025 Q2	$85K	Sell	6,251 -2,091	-25%	-$30.3K	﹤0.01%	2858
2025 Q1	$132K	Buy	8,342 +3,105	+59%	+$35.7K	﹤0.01%	2200
2024 Q4	$64K	Buy	5,237 +14	+0.3%	+$183	﹤0.01%	2605
2024 Q3	$63K	Sell	5,223 -662	-11%	-$8.01K	﹤0.01%	2524
2024 Q2	$69K	Sell	5,885 -6	-0.1%	-$76	﹤0.01%	2237
2024 Q1	$76K	Hold	5,891	–	–	﹤0.01%	2034
2023 Q4	$51K	Buy	5,891 +3,213	+120%	+$25.2K	﹤0.01%	2169
2023 Q3	$25K	Buy	+2,678	New	+$34.9K	﹤0.01%	2531
2023 Q2	–	Sell	-13	Closed	–	–	4355
2023 Q1	$0	Buy	+13	New	+$219	﹤0.01%	4236

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MLYS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Mineralys Therapeutics (MLYS) stake by 19% in Q1 2026, buying an estimated $27.9K and bringing the position to 6,051 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Carson Wealth (CWM LLC) first reported a position in MLYS in Q1 2023 and has held it in 12 quarters since. The position peaked at $212K in Q3 2025. 215 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

Carson Wealth (CWM LLC) held 6,051 shares of Mineralys Therapeutics worth $164K as of Q1 2026.
Carson Wealth (CWM LLC) bought 953 Mineralys Therapeutics shares in Q1 2026, an estimated $27.9K.
Mineralys Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2892 holding.
Carson Wealth (CWM LLC) first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 12 quarters since.
Carson Wealth (CWM LLC)'s Mineralys Therapeutics position peaked at $212K in Q3 2025.
215 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.